RECRUITING

Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

Conditions

Type 1 Diabetes Anesthesia Continuous glucose monitors Accuracy Pediatrics

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

Official Title

Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

Quick Facts

Study Start:2024-08-21

Study Completion:2025-09-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06575842

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 26 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD, ADULT

Inclusion Criteria	Exclusion Criteria
1. Participants will be 2 to 26 years of age at the time of enrollment. 2. Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period. 3. Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.	1. Pregnancy. 2. Currently using hydroxyurea. 3. A condition that the investigator determines would prevent the patient from participation.

Inclusion Criteria

Exclusion Criteria

1. Participants will be 2 to 26 years of age at the time of enrollment.
2. Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.
3. Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.

1. Pregnancy.
2. Currently using hydroxyurea.
3. A condition that the investigator determines would prevent the patient from participation.

Contacts and Locations

Study Contact

Erin Cobry, MD

CONTACT

3037242323

Erin.Cobry@cuanschutz.edu

Study Locations (Sites)

Barbara Davis Center

Aurora, Colorado, 80045

United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-21

Study Completion Date2025-09-01

Study Record Updates

Study Start Date2024-08-21

Study Completion Date2025-09-01

Terms related to this study

Keywords Provided by Researchers

Anesthesia
Continuous glucose monitors
Accuracy
Pediatrics

Additional Relevant MeSH Terms

Type 1 Diabetes